CERO THERAPEUTICS HOLDINGS, INC. Common Stock, Other Shares, Outstanding
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Common Stock, Other Shares, Outstanding of 5.00 million shares as of 2024-09-30, per its 10-Q/A filed 2024-11-20.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockOtherSharesOutstanding · last filed 2024-11-20
- 2024-09-30: Common Stock, Other Shares, Outstanding 5.00M shares.
- 2024-06-30: Common Stock, Other Shares, Outstanding 5.00M shares.
- 2024-03-31: Common Stock, Other Shares, Outstanding 5.00M shares.
| Period end | Common Stock, Other Shares, Outstanding |
|---|---|
| 2024-09-30 | 5.00M shares 10-Q/A · filed 2024-11-20 |
| 2024-06-30 | 5.00M shares 10-Q · filed 2024-08-14 |
| 2024-03-31 | 5.00M shares 10-Q · filed 2024-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |